Czech National Bank Has $5.08 Million Stake in Waters Corporation $WAT

Key Points

• The **Czech National Bank** increased its stake in **Waters Corporation** (NYSE:WAT) by **6.7%**, acquiring a total of **14,546 shares** valued at approximately **$5.08 million**.
Multiple institutional investors have continued to build their positions in Waters, with **94.01%** of the stock now held by institutional investors and hedge funds.
• Waters reported an **EPS of $2.95** for the quarter, surpassing estimates and reflecting an **8.8% revenue increase** year-over-year, with guidance for Q3 2025 set at **$3.150-3.250 EPS**.

Czech National Bank lifted its position in shares of Waters Corporation (NYSE:WAT - Free Report) by 6.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,546 shares of the medical instruments supplier's stock after purchasing an additional 909 shares during the quarter. Czech National Bank's holdings in Waters were worth $5,077,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Waters by 2.4% during the first quarter. Vanguard Group Inc. now owns 7,272,252 shares of the medical instruments supplier's stock worth $2,680,334,000 after purchasing an additional 173,584 shares during the period. Alliancebernstein L.P. grew its holdings in Waters by 15.7% during the first quarter. Alliancebernstein L.P. now owns 3,070,671 shares of the medical instruments supplier's stock worth $1,131,757,000 after buying an additional 416,669 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in Waters by 6.3% during the first quarter. Massachusetts Financial Services Co. MA now owns 2,066,482 shares of the medical instruments supplier's stock worth $761,643,000 after buying an additional 123,215 shares in the last quarter. Invesco Ltd. grew its holdings in Waters by 14.0% during the first quarter. Invesco Ltd. now owns 1,112,128 shares of the medical instruments supplier's stock worth $409,897,000 after buying an additional 136,396 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in Waters by 2.1% during the first quarter. Northern Trust Corp now owns 739,630 shares of the medical instruments supplier's stock worth $272,605,000 after buying an additional 15,563 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Robert W. Baird decreased their price target on Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a report on Wednesday, July 16th. Scotiabank reiterated a "sector outperform" rating and set a $465.00 price target on shares of Waters in a report on Friday, July 11th. Bank of America upped their price target on Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. UBS Group reiterated a "neutral" rating on shares of Waters in a report on Tuesday, July 15th. Finally, Wall Street Zen downgraded Waters from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Waters presently has a consensus rating of "Hold" and an average price target of $378.73.

Waters Stock Up 1.0%

Shares of NYSE WAT opened at $306.80 on Friday. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $423.56. The business has a 50-day simple moving average of $295.98 and a two-hundred day simple moving average of $331.35. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The company has a market cap of $18.26 billion, a P/E ratio of 27.66, a P/E/G ratio of 2.83 and a beta of 1.07.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, topping the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. During the same quarter last year, the company earned $2.63 EPS. The firm's revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Research analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.